About Turbine
Turbine is a company based in Budapest (Hungary) founded in 2015. It operates as a AI-as-a-Service and HealthTech. Turbine has raised $61.68 million across 7 funding rounds from investors including Accenture, Accel and Mercia. Turbine offers products and services including Simulated Cell™, Target Selection, ADC Payloads, Clinical Positioning, and DDR. Turbine operates in a competitive market with competitors including Insitro, BridgeBio, ATAI, Forge Biologics and DNAnexus, among others.
- Headquarter Budapest, Hungary
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Turbine Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$61.68 M (USD)
in 7 rounds
-
Latest Funding Round
$25 M (USD), Series B
Feb 24, 2026
-
Investors
Accenture
& 13 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Turbine
Turbine offers a comprehensive portfolio of products and services, including Simulated Cell™, Target Selection, ADC Payloads, Clinical Positioning, and DDR.
Cell simulation platform is used for drug discovery.
Novel targets are uncovered to expand drug pipelines.
Payloads are simulated to match ADC to patients.
Best responder patients are identified for clinical programs.
Commercial potential of DDRi is unlocked through simulation.
People of Turbine
Unlock access to complete
Unlock access to complete
Funding Insights of Turbine
Turbine has successfully raised a total of $61.68M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $25 million completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Turbine
Turbine has secured backing from 14 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Accenture, Accel and Mercia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate-backed venture capital fund
|
Locked | Locked | Locked | |
|
Early-stage technology ventures are supported by Day One Capital.
|
Locked | Locked | Locked | |
|
Accel is recognized as a leading venture capital firm.
|
Locked | Locked | Locked |
Investor details for Turbine
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Turbine
Investment portfolio details for Turbine
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Turbine
Detailed financials for Turbine
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Turbine Comparisons
Peer comparison for Turbine
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Turbine
Turbine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, ATAI, Forge Biologics and DNAnexus, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases are developed to treat patients.
|
|
| Locked | Locked | Locked |
Cloud-based genome informatics and data management are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
Detailed competitors of Turbine
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Turbine
Complete news archive for Turbine
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Turbine
Turbine was founded in 2015 and raised its 1st funding round 4 years after it was founded.
Turbine is headquartered in Budapest, Hungary.
Turbine is a funded company, having raised a total of $61.68M across 7 funding rounds to date.
Turbine is engaged in developing an AI-powered cell simulation platform named Simulated Cell, aimed at transforming oncology drug discovery and development. The platform is utilized to uncover novel targets, simulate ADC payloads, identify responder patients for clinical programs, and unlock the commercial potential of DDR inhibitors. Solutions offered by Turbine are integrated into various stages of RD, including target discovery, drug discovery, preclinical, early development, and commercialization. The company collaborates with major pharmaceutical partners to provide biology-driven insights and validate potential targets. Turbines technology is designed to augment pipelines by enabling data science-augmented RD and simulation-aided decision-making, impacting multiple application areas within the healthcare and biotechnology sectors.
Turbine's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
Turbine offers Simulated Cell™, Target Selection, ADC Payloads, Clinical Positioning, and DDR.
Turbine has 14 investors. Key investors include Accenture, Accel, Mercia, MassMutual Ventures, and Day One Capital.